Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2017

01-08-2017 | Clinical Practice: Clinical Images

Drug-Induced Sweet‘s Syndrome

Authors: Vivian Tien, MD, Andrew D. Jones, MD, Paul B. Aronowitz, MD

Published in: Journal of General Internal Medicine | Issue 8/2017

Login to get access

Excerpt

A 69-year-old man with ulcerative colitis presented with fever, fatigue, and rash. The patient reported onset of symptoms within 5 days of starting azathioprine. Physical examination revealed a fever of 39.5°C and a painful rash of erythematous plaques with pustules on bilateral elbows and neck (Fig. 1) and scattered macules on bilateral palms. The white blood cell count was 8000/mm3 with 96% neutrophils; the erythrocyte sedimentation rate was 60 mm/h. Biopsy of the elbow lesion revealed a dense dermal neutrophilic infiltrate, lack of perivascular inflammation, and papillary dermal edema consistent with Sweet’s syndrome (Fig. 2). Symptoms and rash rapidly resolved after discontinuing azathioprine.
Literature
2.
go back to reference Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34:918-23. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34:918-23.
3.
go back to reference Imhof L, Meier B, Frei P, et al. Severe Sweet’s syndrome with elevated cutaneous interleukin-1b after azathioprine exposure: case report and review of the literature. Dermatology. 2015;230:293–8.CrossRefPubMed Imhof L, Meier B, Frei P, et al. Severe Sweet’s syndrome with elevated cutaneous interleukin-1b after azathioprine exposure: case report and review of the literature. Dermatology. 2015;230:293–8.CrossRefPubMed
Metadata
Title
Drug-Induced Sweet‘s Syndrome
Authors
Vivian Tien, MD
Andrew D. Jones, MD
Paul B. Aronowitz, MD
Publication date
01-08-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4022-1

Other articles of this Issue 8/2017

Journal of General Internal Medicine 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.